ClinicalTrials.govpublic full text
Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant
refractory multiple myeloma, bortezomib, liposomal doxorubicin, dexamethasone, cyclophosphamide, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 832356
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.